Idiosyncratic Drug-Induced Liver Injury in a Healthy Patient following PCSK9-Inhibitor Injection.

Autor: Stüben, B.-O., Hoyer, D. P., Radunz, S., Saner, F., Schmidt, H., Baba, H. A., Treckmann, J. W., Mazilescu, L. I.

Publikováno v: Case Reports in Hepatology; 1/11/2024, p1-4, 4p

ROS generating BODIPY loaded nanoparticles for photodynamic eradication of biofilms.

Autor: Kromer C; Department Chemicals and Product Safety, Product Materials and Nanotechnology, German Federal Institute for Risk Assessment, Berlin, Germany.; Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany., Schwibbert K; Department Materials and the Environment, Biodeterioration and Reference Organisms, Federal Institute for Materials Research and Testing, Berlin, Germany., Radunz S; nanoPET Pharma GmbH, Berlin, Germany., Thiele D; Department Materials and the Environment, Biodeterioration and Reference Organisms, Federal Institute for Materials Research and Testing, Berlin, Germany., Laux P; Department Chemicals and Product Safety, Product Materials and Nanotechnology, German Federal Institute for Risk Assessment, Berlin, Germany., Luch A; Department Chemicals and Product Safety, Product Materials and Nanotechnology, German Federal Institute for Risk Assessment, Berlin, Germany.; Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany., Tschiche HR; Department Chemicals and Product Safety, Product Materials and Nanotechnology, German Federal Institute for Risk Assessment, Berlin, Germany.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2023 Oct 12; Vol. 14, pp. 1274715. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).

Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by ⁹⁰ Y Radioembolization: A Multicenter Retrospective Study.

Autor: Schaarschmidt BM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany; benedikt.schaarschmidt@uk-essen.de., Kloeckner R; Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Dertnig T; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany., Demircioglu A; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany., Müller L; Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Auer TA; Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany., Santos DPD; Department of Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany., Steinle V; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany., Miederer M; Clinic of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Gebauer B; Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Radunz S; Department of General, Visceral, and Transplant Surgery, University Hospital Essen, Essen, Germany., Kasper S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; and., Weber M; Clinic of Nuclear Medicine, University Hospital Essen, Essen, Germany., Theysohn J; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Apr; Vol. 64 (4), pp. 529-535. Date of Electronic Publication: 2022 Nov 03.

A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).

Autor: Virchow I; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.; Medical Faculty, University Duisburg-Essen, Essen, Germany., Treckmann JW; Medical Faculty, University Duisburg-Essen, Essen, Germany.; West German Cancer Center, Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany., Prasnikar N; Ambulatory Health Care Center for Haematology and Medical Oncology, Hamburg, Germany., Linden G; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany., Markus P; Department of General, Visceral and Trauma Surgery, Elisabeth Hospital Essen, Essen, Germany., Schumacher B; Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany., Albers D; Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany., Herold T; Medical Faculty, University Duisburg-Essen, Essen, Germany.; West German Cancer Center, Institute of Pathology, University Hospital Essen, Essen, Germany., Ting S; Medical Faculty, University Duisburg-Essen, Essen, Germany.; West German Cancer Center, Institute of Pathology, University Hospital Essen, Essen, Germany.; Institute of Pathology Nordhessen, Kassel, Germany., Schmidt H; Medical Faculty, University Duisburg-Essen, Essen, Germany.; Department of Gastroenterology, Hepatology and Transplant Medicine, University Hospital Essen, Essen, Germany., Radunz S; Medical Faculty, University Duisburg-Essen, Essen, Germany.; West German Cancer Center, Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany., Wiesweg M; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.; Medical Faculty, University Duisburg-Essen, Essen, Germany., Siveke J; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.; Medical Faculty, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.; West German Cancer Center, Bridge Institute of Experimental Tumor Therapy, University Hospital Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schuler M; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.; Medical Faculty, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., Kasper S; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.; Medical Faculty, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Publikováno v: Oncology research and treatment [Oncol Res Treat] 2023; Vol. 46 (3), pp. 89-99. Date of Electronic Publication: 2023 Jan 09.

Hyperspectral Imaging for Viability Assessment of Human Liver Allografts During Normothermic Machine Perfusion.

Autor: Kneifel F; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Wagner T; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Flammang I; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Vogt F; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Katou S; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Vogel T; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Houben P; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Becker F; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Wahl P; Diaspective Vision GmbH, Am Salzhaff, Germany., Pascher A; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany., Radunz S; Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany.; Department of General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany.

Publikováno v: Transplantation direct [Transplant Direct] 2022 Nov 17; Vol. 8 (12), pp. e1420. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).